NYSE$CLB
Core Laboratories Inc · Q1 2025 earnings
Q1 2025 earnings · · Investor relations
Briefing
Core Laboratories reported Q1 2025 revenue of $123.6M, a net loss of $154.0K.
For Q1 2025, Core Laboratories reported Revenue was $123.6M, net loss was $154.0K. Management discusses segment trends, liquidity, and outlook in the quarterly filing.
- Revenue $123.6M for Q1 2025.
- Net loss $154.0K.
- MD&A highlights operating priorities, liquidity, and sector risks.
Headline financials
Revenue & EPS history
Core Labs · Revenue · Quarterly
$124M
Forward guidance
Outlook emphasizes milestones, liquidity runway, and cost discipline.
Tailwinds
- Pipeline progress and partnership economics.
- Cash supports near-term operating plans.
Headwinds
- Operating losses until commercial scale.
- Financing and competition affect funding costs.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 9 quarterly earnings reports · overlaid with Q1 2025
+4.1%
Avg return
Earnings day
+2.8%
Avg return
5 days after
-3.7%
Avg return
30 days after
67%
6 / 9 earnings
Positive
+28.8%
Q3 2025
Best reaction
-15.3%
Q1 2026
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -15.3% | -17.7% | -21.2% | |
| Q4 2025 | -4.2% | -4.9% | -18.9% | |
| Q3 2025 | +28.8% | +29.0% | +15.3% | |
| Q1 2025 | +2.2% | -2.1% | -6.5% | |
| Q3 2024 | +10.9% | +14.2% | +24.6% | |
| Q2 2024 | +10.6% | +11.2% | -16.6% | |
| Q1 2024 | +3.3% | -4.4% | +8.4% | |
| Q3 2023 | +1.1% | -10.8% | -14.0% | |
| Q2 2023 | -0.8% | +10.6% | -4.4% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro